Cardiovascular Outcomes With Glucagon-Like Peptide 1 Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes: A Meta-Analysis

Citation
Lee YM, Park EJ, Park YA, et al. Circulation 2019;140(Suppl 1):A12808.